These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 22984934)

  • 1. An update on antidepressant use and suicidality in pediatric depression.
    Adegbite-Adeniyi C; Gron B; Rowles BM; Demeter CA; Findling RL
    Expert Opin Pharmacother; 2012 Oct; 13(15):2119-30. PubMed ID: 22984934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early evidence on the effects of regulators' suicidality warnings on SSRI prescriptions and suicide in children and adolescents.
    Gibbons RD; Brown CH; Hur K; Marcus SM; Bhaumik DK; Erkens JA; Herings RM; Mann JJ
    Am J Psychiatry; 2007 Sep; 164(9):1356-63. PubMed ID: 17728420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antidepressants and suicidality: the basis of controversies.
    Marcinko D
    Psychiatr Danub; 2007 Sep; 19(3):238-40. PubMed ID: 17914327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Newer generation antidepressants for depressive disorders in children and adolescents.
    Hetrick SE; McKenzie JE; Cox GR; Simmons MB; Merry SN
    Cochrane Database Syst Rev; 2012 Nov; 11(11):CD004851. PubMed ID: 23152227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antidepressants use in pediatric populations.
    Gören JL
    Expert Opin Drug Saf; 2008 May; 7(3):223-5. PubMed ID: 18462180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between antidepressant half-life and the risk of suicidal ideation or behavior among children and adolescents: confirmatory analysis and research implications.
    Smith EG
    J Affect Disord; 2009 Apr; 114(1-3):143-8. PubMed ID: 18692250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of publicity concerning pediatric suicidality data on physician practice patterns in the United States.
    Nemeroff CB; Kalali A; Keller MB; Charney DS; Lenderts SE; Cascade EF; Stephenson H; Schatzberg AF
    Arch Gen Psychiatry; 2007 Apr; 64(4):466-72. PubMed ID: 17404123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do antidepressants t(h)reat(en) depressives? Toward a clinically judicious formulation of the antidepressant-suicidality FDA advisory in light of declining national suicide statistics from many countries.
    Rihmer Z; Akiskal H
    J Affect Disord; 2006 Aug; 94(1-3):3-13. PubMed ID: 16712945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative safety of antidepressant agents for children and adolescents regarding suicidal acts.
    Schneeweiss S; Patrick AR; Solomon DH; Dormuth CR; Miller M; Mehta J; Lee JC; Wang PS
    Pediatrics; 2010 May; 125(5):876-88. PubMed ID: 20385637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antidepressant class, age, and the risk of deliberate self-harm: a propensity score matched cohort study of SSRI and SNRI users in the USA.
    Miller M; Pate V; Swanson SA; Azrael D; White A; Stürmer T
    CNS Drugs; 2014 Jan; 28(1):79-88. PubMed ID: 24146116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antidepressant drugs and the risk of suicide in children and adolescents.
    Isacsson G; Rich CL
    Paediatr Drugs; 2014 Apr; 16(2):115-22. PubMed ID: 24452997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depression, antidepressants and suicidality: a critical appraisal.
    Licinio J; Wong ML
    Nat Rev Drug Discov; 2005 Feb; 4(2):165-71. PubMed ID: 15688079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of selective serotonin reuptake inhibitors in children and adolescents.
    Wong IC; Besag FM; Santosh PJ; Murray ML
    Drug Saf; 2004; 27(13):991-1000. PubMed ID: 15471506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pediatric antidepressant use after the black-box warning.
    Busch SH; Barry CL
    Health Aff (Millwood); 2009; 28(3):724-33. PubMed ID: 19414881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antidepressants and suicide in adolescents].
    Silva M; Sampaio D
    Acta Med Port; 2011; 24(4):603-12. PubMed ID: 22521018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Selective serotonin reuptake inhibitors in major depressive disorder in children and adolescents (ratio of benefits/risks)].
    Hjalmarsson L; Corcos M; Jeammet P
    Encephale; 2005; 31(3):309-16. PubMed ID: 16142045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pediatric prescribing practices and the FDA Black-box warning on antidepressants.
    Cheung A; Sacks D; Dewa CS; Pong J; Levitt A
    J Dev Behav Pediatr; 2008 Jun; 29(3):213-5. PubMed ID: 18550990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of regulatory warnings on antidepressant prescription rates, use of health services and outcomes among children, adolescents and young adults.
    Katz LY; Kozyrskyj AL; Prior HJ; Enns MW; Cox BJ; Sareen J
    CMAJ; 2008 Apr; 178(8):1005-11. PubMed ID: 18390943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective serotonin reuptake inhibitors (SSRIs) for depressive disorders in children and adolescents.
    Hetrick S; Merry S; McKenzie J; Sindahl P; Proctor M
    Cochrane Database Syst Rev; 2007 Jul; (3):CD004851. PubMed ID: 17636776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antidepressants and suicide risk in the United States, 1985-1999.
    Grunebaum MF; Ellis SP; Li S; Oquendo MA; Mann JJ
    J Clin Psychiatry; 2004 Nov; 65(11):1456-62. PubMed ID: 15554756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.